Asymmetric dimethylarginine and critical illness

被引:3
|
作者
Brinkmann, Saskia J. H. [1 ,2 ]
de Boer, Myrte C. [2 ]
Buijs, Nikki [2 ]
van Leeuwen, Paul A. M. [2 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Plast & Reconstruct Surg, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Surg, NL-1007 MB Amsterdam, Netherlands
关键词
NITRIC-OXIDE; ILL PATIENTS; ENDOTHELIAL DYSFUNCTION; DIMETHYLAMINOHYDROLASE ACTIVITY; CARDIOVASCULAR-DISEASE; PLASMA-CONCENTRATIONS; RENAL-DISEASE; ORGAN FAILURE; SEPTIC SHOCK; ARGININE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:90 / 97
页数:8
相关论文
共 50 条
  • [1] Assessment of asymmetrical dimethylarginine metabolism in patients with critical illness
    Ghashut, Rawia A.
    Blackwell, Scott
    Ryan, Sylvia
    Willox, Laura
    McMillan, Donald C.
    Kinsella, John
    Talwar, Dinesh
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 (04) : 279 - 288
  • [2] Mortality in critical illness: The impact of asymmetric dimethylarginine on survival-A systematic review and meta-analysis
    Mortensen, Karoline Myglegard
    Itenov, Theis Skovsgaard
    Hansen, Marco Bo
    Hvid, Karen
    Lundstrom, Lars Hyldborg
    Bestle, Morten Heiberg
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2019, 63 (06) : 708 - 719
  • [3] Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness
    Davids, Mariska
    Richir, Milan C.
    Visser, Marlieke
    Ellger, Bjorn
    van den Berghe, Greet
    van Leeuwen, Paul A. M.
    Teerlink, Tom
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2012, 61 (04): : 482 - 490
  • [4] Asymmetric Dimethylarginine (ADMA) in cardiovascular and renal disease
    Alpoim, Patricia Nessralla
    Nunes Sousa, Leticia Parreiras
    Lucas Mota, Ana Paula
    Alves Rios, Danyelle Romana
    SantAna Dusse, Luci Maria
    CLINICA CHIMICA ACTA, 2015, 440 : 36 - 39
  • [5] Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease
    Franceschelli, Sara
    Ferrone, Alessio
    Pesce, Mirko
    Riccioni, Graziano
    Speranza, Lorenza
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (12): : 24412 - 24421
  • [6] The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients
    Richir, M. C.
    Ellger, B.
    Teerlink, T.
    Siroen, M. P. C.
    Visser, M.
    Spreeuwenberg, M.
    Girbes, A. R. J.
    van der Hoven, B.
    van den Berghe, G.
    Wilhelm, A. J.
    de Vries, Th. P. G. M.
    van Leeuwen, P. A. M.
    PHARMACOLOGICAL RESEARCH, 2009, 60 (06) : 519 - 524
  • [7] Asymmetric Dimethylarginine Responses During Interferon-α-Induced Depression in Patients With Chronic Hepatitis C Infection
    Baranyi, Andreas
    Meinitzer, Andreas
    Putz-Bankuti, Csilla
    Stauber, Rudolf
    Kapfhammer, Hans-Peter
    Rothenhaeusler, Hans-Bernd
    PSYCHOSOMATIC MEDICINE, 2014, 76 (03): : 197 - 207
  • [8] Cardiovascular risk factors and the concentration of asymmetric dimethylarginine
    Gac, Pawel
    Poreba, Malgorzata
    Jurdziak, Marta
    Trzmielewska, Ewa
    Goclawska, Katarzyna
    Derkacz, Arkadiusz
    Mazur, Grzegorz
    Szuba, Andrzej
    Poreba, Rafal
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (01): : 63 - 70
  • [9] Asymmetric Dimethylarginine, Endothelial Dysfunction and Renal Disease
    Aldamiz-Echevarria, Luis
    Andrade, Fernando
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (09) : 11288 - 11311
  • [10] Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis
    Lluch, Paloma
    Segarra, Gloria
    Medina, Pascual
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (32) : 9466 - 9475